- Clinical trials are research studies that test whether a new treatment is safe and effective; they are research, not guaranteed treatment.
- HIV research spans new antiretroviral drugs, long-acting therapies, prevention approaches, and studies working toward a cure.
- You can search current HIV studies on ClinicalTrials.gov, a US government registry, and through NIH-supported research networks.
- Informed consent means you get full information about a study, can ask questions, and can withdraw at any time.
- Living with HIV is a manageable health condition, and participating in research is a personal choice made with your care team.
- Never stop or change your antiretroviral therapy on your own to join a trial; coordinate every change with your HIV doctor.
Thanks to decades of research, HIV is now a manageable chronic health condition for many people, and studies continue to improve treatment, prevention, and quality of life. Clinical trials are one of the ways new options are tested. But a trial is a research study, not guaranteed therapy, so it helps to understand how they work before considering one. This guide explains what HIV clinical trials are, the phases involved, how to find studies, and what informed consent means, so you can have a well-prepared conversation with your HIV care provider.
What is a clinical trial?
A clinical trial is a research study that tests a medical approach, such as a new medication, prevention method, or treatment strategy, in people. The goal is to answer specific questions: Is it safe? What dose works best? Does it help more than existing options? Because these questions are still being answered, participation involves some uncertainty. A trial is designed to generate knowledge, and while participants may benefit, benefit is never guaranteed and is not the study’s only purpose.
HIV research is broad. Trials may study new antiretroviral medications, long-acting injectable treatments, approaches to prevention (such as pre-exposure prophylaxis), treatments for related conditions, and research aimed at long-term remission or a cure. Some studies focus on people who are newly diagnosed, and others on people who have lived with HIV for years.
The phases of drug trials
New drugs generally move through a series of phases, each with a different question and size.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what is a tolerable dose? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo? | Large groups, often at multiple sites |
| Phase 4 | What are the long-term effects after approval? | Post-approval monitoring |
Many trials use a control group and randomization, and some are “blinded,” meaning participants (and sometimes researchers) do not know who receives the investigational treatment versus a comparison. These designs help produce reliable answers, but they also mean you may not receive the new treatment. You can see the same structure in how trials work for other conditions.
How to search for HIV trials
The main US resource is ClinicalTrials.gov, a registry run by the National Institutes of Health that lists clinical studies conducted around the world. You can search by condition (such as “HIV”), location, and recruitment status. Each listing describes the study’s purpose, eligibility criteria, locations, and contact information. NIH-supported research networks, academic medical centers, and community health organizations may also share opportunities. As you read listings, note the eligibility rules: inclusion criteria (characteristics you must have) and exclusion criteria (things that would keep you out), which often relate to treatment history, other health conditions, and lab measures. For context on how research and everyday care fit together, our evidence-first wellness guides take a careful approach throughout.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and you can decline without affecting your regular care.
- You can withdraw from a study at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board) that helps protect participants.
- Your privacy and confidentiality are protected under the study’s rules.
- You should understand any costs, travel, time commitment, and what happens to your treatment when the study ends.
Consent is an ongoing conversation, not just a signature.
Talk with your HIV care provider first
Joining a trial is a medical decision, so involve the doctor who manages your HIV. Modern antiretroviral therapy is highly effective, and staying on consistent treatment keeps many people healthy and can reduce transmission risk. For that reason, never stop or change your antiretroviral therapy on your own to qualify for or join a study. Let your care team and the research team coordinate any changes safely. Research participation is a personal choice, and it is one you can make with full support. If you are exploring studies for co-occurring conditions, the same principles apply to clinical trials for PTSD and other areas.
Frequently asked questions
Will a clinical trial cure my HIV? No trial can promise that. Some research works toward long-term remission, but trials test safety and effectiveness, and benefit is possible but not guaranteed.
Where do I find HIV trials? ClinicalTrials.gov is the main US registry. Academic centers, NIH research networks, and community organizations may also list opportunities.
Do I have to pay to join? Study treatment is often provided, but costs vary. Ask about any expenses, travel, and what is covered before enrolling.
Might I receive a placebo? It depends on the study design. Ethical trials generally do not withhold effective standard treatment; the consent process will explain exactly what each group receives.
Is my information kept private? Yes. Studies follow strict confidentiality rules, and the consent form explains how your data is protected.
Should I stop my medication to qualify? Never do this on your own. Any change must be guided by your HIV doctor and the research team.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- NIH National Institute of Allergy and Infectious Diseases (NIAID) — HIV/AIDS research information
- Centers for Disease Control and Prevention (CDC) — HIV treatment, prevention, and living well
- MedlinePlus — HIV/AIDS and clinical trials overviews